{
    "nctId": "NCT03868514",
    "briefTitle": "Post Market Clinical Follow Up to \"Patient Reported Outcome\" Using a Titanised Polypropylene Mesh (TiLOOP\u00ae Bra Pocket)",
    "officialTitle": "\"PRO-Pocket\" - International Prospective Multicenter Post Market Clinical Follow Up to \"Patient Reported Outcome\" in Primary or Secondary Breast Reconstruction After Mastectomy Using a Titanised Polypropylene Mesh (TiLOOP\u00ae Bra Pocket)",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Reconstruction After Mastectomy, Breast Neoplasm, Breast Cancer, Breast Diseases",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 313,
    "primaryOutcomeMeasure": "Quality of Life - Patient reported outcome",
    "eligibilityCriteria": "Inclusion Criteria:\n\nAge \\[\u2265 18\\]\n\nIndications of breast reconstruction: histologically confirmed breast cancer, precancerous lesions (DCIS, LCIS), mutation carrier with increased breast cancer risk, strong family history (lifetime risk \\> 15%)\n\nThe patient is capable to realise the nature, aims and possible consequences of the clinical trial (MPG \u00a720.2.1)\n\nPatient information has been provided and all written consents of the patient are available\n\nExclusion Criteria:\n\nMetastatic breast cancer\n\nPatient with known contraindications against mesh-assisted or plastic-reconstructive breast surgery according to the instruction for use\n\nPatient is kept in an institution under judicial or official orders (MPG \u00a720.3)\n\nParticipate in another operative clinical trial, if it relates to the area of reconstructive breast surgery and/or influences the primary endpoint of the clinical trial",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}